[EN] INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE<br/>[FR] INHIBITEURS DE L'INDOLÉAMINE 2,3-DIOXYGÉNASE ET LEURS PROCÉDÉS D'UTILISATION
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2020023356A1
公开(公告)日:2020-01-30
The present invention provides compounds of formula (I) wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.
DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
申请人:JAPAN TOBACCO INC.
公开号:US20160194290A1
公开(公告)日:2016-07-07
A compound of Formula [I] or a pharmaceutically acceptable salt thereof:
wherein each symbol is defined as in the specification.
化合物的结构式[I]或其药用盐:其中每个符号的定义如规范中所述。
CLEAVAGE OF VINYL CARBON–SILICON BOND IN γ-TRIMETHYLSILYL ALLYLIC ALCOHOLS
作者:M. I. Al-Hassan、R. B. Miller
DOI:10.1081/scc-100107013
日期:2001.1
Cleavage of the vinyl carbon–siliconbond by fluoride ion requires a free hydroxyl group located in such a position that stable cyclic transition state can be attained.
氟离子对乙烯基碳-硅键的裂解需要一个游离羟基,该羟基位于可以达到稳定环状过渡态的位置。
DIHYDROPYRIMIDINE-2-ONE COMPOUNDS AND MEDICINAL USES THEREOF
申请人:JAPAN TOBACCO INC.
公开号:EP3231793A1
公开(公告)日:2017-10-18
A compound of Formula [I] or a pharmaceutically acceptable salt thereof:
wherein each symbol is defined as in the specification.
式 [I] 的化合物或其药学上可接受的盐:
其中各符号定义如说明书。
DIYHYDROPYRIMIDINE-2-ONE COMPOUNDS AND MEDICINAL USES THEREOF
申请人:Japan Tobacco Inc.
公开号:EP3744713A1
公开(公告)日:2020-12-02
A RORγ inhibitor of Formula [I] or a pharmaceutically acceptable salt thereof:
wherein each symbol is defined as in the specification.